MoneyWorks4Me

The sales for the March 2024 quarter moved up 47.90% to Rs. 1180.33 millions as compared to Rs. 798.04 millions during the corresponding quarter last year.An average growth of 30.09% was recorded for the quarter ended March 2024 to Rs. 50.63  millions from Rs. 38.92 millions.Operating Profit reported a sharp decline to 111.67 millions from 122.60 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 1180.33 798.04 47.90 3490.72 2764.98 26.25 3490.72 2764.98 26.25
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBIDT 111.67 122.60 -8.92 388.98 296.00 31.41 388.98 296.00 31.41
Interest 43.72 35.54 23.02 136.50 92.82 47.06 136.50 92.82 47.06
PBDT 67.95 87.06 -21.95 252.48 203.18 24.26 252.48 203.18 24.26
Depreciation 9.56 6.99 36.77 37.96 28.09 35.14 37.96 28.09 35.14
PBT 58.39 80.07 -27.08 214.52 175.09 22.52 214.52 175.09 22.52
TAX 7.76 41.15 -81.14 58.28 67.02 -13.04 58.28 67.02 -13.04
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 50.63 38.92 30.09 156.24 108.07 44.57 156.24 108.07 44.57
Equity 46.99 45.32 3.68 46.99 45.32 3.68 46.99 45.32 3.68
PBIDTM(%) 9.46 15.36 -38.42 11.14 10.71 4.09 11.14 10.71 4.09
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..